Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-07-18

FDA Approved: OMEPRAZOLE AND SODIUM BICARBONATE — Supplemental Application (Oceanside Pharmaceuticals)

View source ↗

Summary

The FDA approved Oceanside Pharmaceuticals' supplemental application for omeprazole and sodium bicarbonate, updating the product labeling accordingly.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Omeprazole and sodium bicarbonate (omeprazole and sodium bicarbonate)

Snippet

SUPPL AP for OMEPRAZOLE AND SODIUM BICARBONATE (OMEPRAZOLE, SODIUM BICARBONATE)